Ross Mantle for STAT

STAT+ | Ohio governor’s race is a battle over Covid, health costs, and trust in science

Race between Amy Acton and Vivek Ramaswamy is being shaped by affordable insurance, Medicaid cuts, vaccine policy, trust in science, and lessons from Covid.

By Sarah Todd

STAT+ | HHS unveils new initiatives to reduce animal testing in drug development

Studies have indicated about 90% of drugs shown to be safe and effective in animals during early-stage testing do not work as hoped in humans

By Ed Silverman

STAT+ | Why an influential GOP health policy expert still backs the Medicaid cuts — and which policy target is next

Q&A with Brian Blase, influential GOP health care policy wonk, on how to trim Medicaid funding and why the No Surprises Act 'has been a complete disaster.'

By Daniel Payne

Finn Gomez/Getty Images

STAT+ | Members of Congress push back on plan to create a commission of political appointees to review NIH grants

Trump reportedly asked Vought to draft an order creating a panel of political appointees to review grants, sparking pushback from senators.

By Anil Oza and Chelsea Cirruzzo

Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?

Research shows that specific integrative therapties reduce cancer-related pain, fatigue, anxiety, and nausea. Why won't insurance pay?

By Lorenzo Cohen

STAT+ | Did the Trump administration just cut Novo a huge financial win?

In today's health policy news: With Trump's drug pricing plan, GLP-1 weight loss drugs may be a huge exception to a Medicaid pilot program

By John Wilkerson

Kevin Dietsch/Getty Images

Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA

Ahead of Heidi Overton’s confirmation hearing for FDA commissioner, two former commissioners review her experience and approach.

By Scott Gottlieb and Mark B. McClellan